Project Grant R21HG012881

Award Date 9/5/23
Completion Date 8/31/25
Dollars Obligated $408K
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Wisconsin, USA
Similar Awards
The National Human Genome Research Institute (NHGRI) awarded a $1,038,898.88 Project Grant (CFDA 93.172 - Human Genome Research) to the Dana-Farber Cancer Institute, Inc. for a 5-year research project titled "Integrative Modelling of Single-Cell Data to Elucidate the Genetic Architecture of Complex Disease." The key objectives are to: 1) Leverage single-cell epigenetic data to identify heritable components of disease; 2) Use single-cell data to fine-map disease variants and mechanisms;...
The National Human Genome Research Institute (NHGRI) awarded a $400,000 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Washington to develop new single-cell multi-omic technologies for studying the relationship between three-dimensional genome organization and gene expression. Specifically, the grant will fund the development of CARE-Seq, a novel method to jointly measure whole-genome chromatin interactions and gene expression in the same single cells from complex...
This federal Project Grant award from the National Human Genome Research Institute (NHGRI), part of the Human Genome Research program (CFDA 93.172), provides $1,341,011 to the University of Pittsburgh for a 5-year research project. The key objective is to develop a computational framework that integrates deep learning and causal discovery algorithms to unveil individualized cell-cell communication networks underlying tissue environment heterogeneity. The research will leverage single-cell...
This Project Grant award, ID K99HG013343, was provided by the National Human Genome Research Institute (NHGRI), which administers the Human Genome Research federal grant program (CFDA 93.172). The $129,723 award, with a project period from September 4, 2024 to August 31, 2026, supports the development of semi-supervised machine learning integration tools to predict various single-cell profiles (e.g., chromatin accessibility, spatial locations, proteomics) from gene expression data. The...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $533,801.84 Project Grant to The Trustees of the University of Pennsylvania to conduct research on determining the regulatory networks underlying human complex traits. The research aims to leverage recent developments in causal inference to integrate large-scale data generation efforts and highlight regulatory changes that contribute to common diseases. The project...
The National Human Genome Research Institute (NHGRI) awarded a $1,205,737.49 Project Grant under the Human Genome Research program (CFDA 93.172) to the University of California, Berkeley. The 4-year grant, awarded on September 10, 2024, supports the development of scalable computational methods and software tools to enable more robust and efficient analysis of large genomic datasets. Specifically, the project aims to: 1) Develop novel maximum likelihood estimation techniques to accelerate...
This $501,191.23 Project Grant awarded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) supports research at the University of Texas MD Anderson Cancer Center to develop advanced computational models for analyzing single-cell genomics data. The key products and services to be delivered include: Creating a "single-cell gene-body associating domain (scGAD)" scoring system to explore 3D genome structures at the gene level and...
The National Human Genome Research Institute (NHGRI), through the Human Genome Research program (CFDA 93.172), awarded a $444,125 Project Grant to the Rector & Visitors of the University of Virginia (UVA) to develop computational models that accurately quantify open chromatin bias and TN5 intrinsic cleavage bias in both bulk and single-cell Cleavage Under Targets & Tagmentation (CUT & TAG) data. The models will characterize how these biases affect the detection of histone...
The University of Washington was awarded a $504,949 Project Grant from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to develop a series of machine learning models that integrate Hi-C data with other genomic data types such as RNA-seq, genome sequence, and ATAC-seq. The goal is to advance the analysis of chromatin structure and its relationship to gene expression and other cellular processes. Key objectives include: Extending the SAGITTARIUS model to...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research (CFDA 93.172) program, awarded a $1,350,896 Project Grant to the University of California, San Diego (UCSD) to develop novel technologies for studying regulatory sequence function. The overarching goal is to create a multimodal platform using massively parallel reporter assays to elucidate the mechanisms governing transcriptional regulation by chromatin, regulatory factors, and transcriptional processes. The...

The National Human Genome Research Institute (NHGRI) awarded the University of Wisconsin System a $407,645 Project Grant under the "Human Genome Research" (CFDA 93.172) program to develop statistical methods for constructing gene co-expression networks from population-scale single-cell RNA sequencing (scRNA-seq) data. The two-year project aims to: 1) develop a de-biasing approach to estimate gene-gene correlations from scRNA-seq data, accounting for technical limitations like low sequencing depth and data sparsity; and 2) innovate a regularized spectral clustering method to infer dynamic gene modules from subject-level and time/perturbation-level co-expression networks. Successful completion of this work will deliver foundational methods and software applicable to analyzing population-scale scRNA-seq datasets across a range of biological applications.

Generated 7/16/24, 6:47 AM